PMCF Study on Monofocal Toric IOL (PODEYE TORIC)

Inclusion Criteria: * Male or female adults ages 50 years or older on the day of screening who have clinically documented cataracts in both eyes; * Calculated IOL power (sphere and cylinder) is within the range of the investigational IOLs; * Regular corneal astigmatism (measured by a topographer); * Corneal astigmatism ≥0.75 D and ≤ 4.25 D (measured by an automatic keratometer) in one or both eyes; * Capability to understand and sign an IRB approved informed consent form and privacy authorization; * Clear intraocular media other than cataract; * Dilated pupil size large enough to visualize IOL axis markings postoperatively; * Best corrected visual acuity projected to be better than 0.2 logMAR after toric IOL implantation; * Willing and able to conform to the study requirements. Exclusion Criteria: * Age of patient \<50 years at the day of screening; * Regular corneal astigmatism \<0.75 D or \>4.25 D (measured by an automatic keratometer) in both eyes * Irregular astigmatism (measured by a topographer); * Subjects with diagnosed degenerative visual disorders (e.g. macular degeneration or other retinal or optic disorders); * Subjects with AMD suspicious eyes as determined by OCT examination; * Previous intraocular or corneal surgery; * Traumatic cataract; * History or presence of macular edema; * Instability of keratometry or biometry measurements; Acceptable maximum standard deviation: AL: ± 150 µm; ACD: ± 150 µm; K1 / K2: ± 0.15 D; * Clinically significant, uncontrolled glaucoma with expected negative impact on Contrast Sensitivity and/or visual acuity outcomes; * Pregnant, lactating or, if able to bear children, unwilling to use medically acceptable birth control over the course of the study; * Concurrent or previous (within 30 days) participation in another drug or device investigation; * Clinically significant dry eye as determined by the investigator' s judgement; * Ocular surface disease (clinical symptoms or keratitis); * Patients showing contraindications as listed in the current Instructions for use (IFU); * Unsuitable for study participation for any other reason, as determined by Investigator's clinical judgment (reason to be documented on eCRF). In addition to above mentioned in- and exclusion criteria, subjects shall be discontinued when certain conditions are present at the time of surgery, including: * zonular instability; * need for iris manipulation; * capsular fibrosis or other opacity; and * inability to fixate IOL in desired position. In such cases, the subject shall be followed until the condition has stabilized.